KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Change in Acquisitions & Divestments (2016 - 2023)

Historic Change in Acquisitions & Divestments for Amgen (AMGN) over the last 15 years, with Q4 2023 value amounting to -$2.0 million.

  • Amgen's Change in Acquisitions & Divestments fell 10029.72% to -$2.0 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$2.0 million, marking a year-over-year decrease of 10011.12%. This contributed to the annual value of $1.1 billion for FY2023, which is 26.79% up from last year.
  • Amgen's Change in Acquisitions & Divestments amounted to -$2.0 million in Q4 2023, which was down 10029.72% from $1.0 million recorded in Q2 2023.
  • In the past 5 years, Amgen's Change in Acquisitions & Divestments registered a high of $10.5 billion during Q1 2019, and its lowest value of -$2.0 million during Q4 2023.
  • In the last 5 years, Amgen's Change in Acquisitions & Divestments had a median value of $1.1 billion in 2023 and averaged $1.9 billion.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first skyrocketed by 14000000.0% in 2021, then plummeted by 10029.72% in 2023.
  • Quarter analysis of 5 years shows Amgen's Change in Acquisitions & Divestments stood at $2.1 billion in 2019, then dropped by 15.33% to $1.8 billion in 2020, then tumbled by 49.33% to $904.0 million in 2021, then dropped by 25.55% to $673.0 million in 2022, then crashed by 100.3% to -$2.0 million in 2023.
  • Its Change in Acquisitions & Divestments stands at -$2.0 million for Q4 2023, versus $1.0 million for Q2 2023 and $1.1 billion for Q1 2023.